---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-007614"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:34:32.068191+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organovo settles patent disputes with BICO; receives $1.5M upfront and ongoing royalties

## Summary
- BICO will pay Organovo $1.5M upfront plus ongoing low-to-high single-digit % royalties on net sales of licensed products.
- All civil actions and IPR proceedings between the parties dismissed and terminated.
- BICO receives worldwide non-exclusive license to Organovo's foundational bioprinting patent portfolio.
- License covers all BICO brands and is perpetual until last patent expires; customary termination provisions included.

## SEC filing metadata
- accession: 0001564590-22-007614
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000156459022007614/0001564590-22-007614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000156459022007614/onvo-8k_20220222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-007614
- JSON: https://secwatch.observer/filing/0001564590-22-007614.json
- Plain text: https://secwatch.observer/filing/0001564590-22-007614.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.